Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Delta-opioid receptor activation as preconditioning, similar to natural hibernation

July 12, 1999

Phase III combination trial begins for ranolazine in stable angina

July 9, 1999

ACE inhibitor quinaprilat stimulates angiogenesis in vivo

July 9, 1999

E-047/1: Ebewe reports pharmacological profile and promising early clinical results

July 8, 1999

GYKI-16638: structure and electrophysiological properties presented at scientific meeting

July 8, 1999

Effects of NOS gene therapy on atherogenic markers in cholesterol-fed rabbits

July 8, 1999

Antiarrhythmic effect of Z-13752A, a dual ACE/NEP inhibitor, is mediated by bradykinin

July 7, 1999

New milrinone analogues exhibit superior inotropic activity and high safety

July 7, 1999

Dual-acting piperazines inhibit TNF-alpha production, stimulate IL-10 production

July 7, 1999

Cell Genesys and Mitotix make progress toward a gene therapy product for restenosis

July 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...